New York, June 13, 2026, 15:06 (ET).
- Altria Group, Inc. rose 0.74% to close Friday at $71.94, recovering part of Thursday’s 2.35% drop.
- The next near-term date is June 15, when Altria trades ex-dividend for its $1.06 quarterly payout; the larger operating catalyst is the July 30 Q2 earnings call.
- With the stock near analysts’ average 12-month target and offering a yield near 5.9%, MO looks fairly valued but still risk-sensitive.
Altria Group, Inc. shares ended Friday at $71.94, up $0.53, or 0.74%, after trading between $71.14 and $72.02, with volume of about 8.41 million shares. The rebound followed a sharper Thursday decline, when MO fell 2.35% even as the S&P 500 and Dow Jones Industrial Average rose, a sign that tobacco-specific concerns outweighed the broader market’s strength for a day. Stocks generally rise when investors are willing to pay more for future earnings and dividends, and fall when risks, valuation pressure or weaker growth expectations reduce that willingness.
The move matters because Altria is being priced less like a fast-growth consumer company and more like an income stock. Its dividend yield — the annual dividend divided by the share price — was listed at 5.89%, while the price-to-earnings ratio, or share price divided by earnings per share, stood at about 15.0. That combination can support the stock when bond yields or defensive demand favor dividends, but it also leaves less room for disappointment if cigarette volumes, regulation or smoke-free products weaken.
The most immediate event is mechanical: Altria’s board declared a regular quarterly dividend of $1.06 per share, payable July 10 to shareholders of record as of June 15, with the ex-dividend date also set for June 15. The ex-dividend date is the first trading day when new buyers are no longer entitled to the next dividend, so income-focused investors often watch it closely; share prices can also adjust around that date to reflect the payout.
The company’s latest major operating update remains its first-quarter report. Altria posted Q1 adjusted diluted EPS — earnings per share excluding certain special items — of $1.32, up 7.3%, on net revenue of $5.43 billion, and reaffirmed full-year 2026 adjusted diluted EPS guidance of $5.56 to $5.72. Then-CEO Billy Gifford said Altria had “delivered a strong start to the year,” while the company also said guidance now reflects moderated e-vapor industry growth and increased macroeconomic uncertainty facing adult nicotine consumers. SEC
The bull case is that Altria still generates large cash returns, has pricing power in its core tobacco business, and is expanding beyond cigarettes. The company paid $1.8 billion in dividends in the first quarter, had $720 million remaining under its $2 billion share-repurchase program as of March 31, and expanded on! PLUS nicotine pouches nationwide after FDA authorization. Buybacks reduce the share count, which can lift EPS if profits hold steady.
The bear case is that Altria’s premium cigarette business remains exposed to long-term volume decline, discount competition and regulatory risk, while the transition into smoke-free products is competitive and uneven. Recent FDA scrutiny of flavored e-cigarette authorizations also shows how quickly the regulatory backdrop for nicotine alternatives can become a stock issue, even when the news is not directly about Altria.
The next major catalyst investors should watch is Altria’s Q2 2026 earnings conference call on July 30 at 9:00 a.m. ET. It will test whether management can keep the full-year EPS range intact, show progress in on! PLUS and other smoke-free products, and explain cigarette shipment trends under new CEO Sal Mancuso, who succeeded Gifford after the May 14 annual meeting.
At Friday’s close, Altria looks fairly valued rather than obviously cheap. Google Finance showed an average 12-month analyst price target of $71.75, slightly below the $71.94 closing price, with a high target of $77 and a low of $64. The dividend keeps MO attractive for income investors who accept tobacco-sector risk, but the stock looks risky for buyers expecting rapid capital appreciation unless July earnings show stronger volume, smoke-free growth or guidance momentum.
